PetMed Express, Inc. (PETS) Stake Lifted by Teachers Advisors LLC

The ratio fall, as 87 investment professionals increased and started new equity positions, while 59 cut down and sold holdings in Petmed Express Inc. The fund owned 6,872 shares of the company's stock after selling 7,058 shares during the quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Fisher Asset Management, LLC controls 126,797 shares with a value of $4,203,000. Oaktop Capital Management II L.P. acquired a new position in PetMed Express in the second quarter worth $15,171,000.

Petmed Express Inc (NASDAQ:PETS) institutional sentiment decreased to 1.47 in Q2 2017. Rhumbline Advisers raised its stake in PetMed Express by 0.4% in the second quarter. Texas Permanent School Fund now owns 15,637 shares of the company's stock valued at $317,000 after buying an additional 204 shares in the last quarter.

Zurich Insurance Group Ltd FI acquired a new stake in shares of PetMed Express, Inc. Gotham Asset Limited Liability Company owns 32,374 shares for 0.02% of their portfolio.

Citigroup Inc. lowered its holdings in PetMed Express, Inc.

Douglass Winthrop Advisors Llc decreased Kimberly (KMB) stake by 33.79% reported in 2017Q2 SEC filing. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & worldwide copyright & trademark law. The legal version of this report can be read at https://www.dispatchtribunal.com/2017/10/19/petmed-express-inc-pets-stake-lifted-by-teachers-advisors-llc.html. The stock was sold at an average price of $49.18, for a total transaction of $122,950.00. Following the completion of the sale, the director now owns 88,834 shares in the company, valued at approximately $4,368,856.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ronald J. Korn sold 5,000 shares of PetMed Express stock in a transaction dated Friday, July 28th. Insiders sold a total of 19,333 shares of company stock valued at $949,730 in the last ninety days. Following the transaction, the chief executive officer now owns 590,000 shares of the company's stock, valued at approximately $12,761,700. The disclosure for this sale can be found here. The insider ROSENBLOOM BRUCE S sold 9,000 shares worth $243,000. Petmed Express Inc (NASDAQ:PETS) has risen 91.46% since October 19, 2016 and is uptrending. (NASDAQ:PETS) opened at 37.21 on Thursday. The firm has a market cap of $755.07 million, a price-to-earnings ratio of 28.62 and a beta of 1.03. Company shares last traded at $36.14 just a bit higher than the 50 day moving average which is $35.64 and a tad higher than the 200 day moving average of $35.80.

PetMed Express (NASDAQ:PETS) last issued its earnings results on Monday, October 24th. Over the past five trading sessions it is 1.21%; 0.87% for the month; -11.52% for the last quarter; 58.51% for the past six-months; and 71.63% for the last 12 months. The firm had revenue of $79.66 million for the quarter, compared to the consensus estimate of $77.32 million. PetMed Express had a return on equity of 28.67% and a net margin of 10.34%. The business's quarterly revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.32 earnings per share.

A number of research analysts recently commented on PETS shares. Sei holds 0% of its portfolio in Petmed Express Inc (NASDAQ:PETS) for 7 shares. Credit Suisse Group reiterated an "underperform" rating and issued a $19.00 price objective on shares of PetMed Express in a report on Monday, October 2nd. The stock of Petmed Express Inc (NASDAQ:PETS) has "Hold" rating given on Tuesday, July 11 by Craig Hallum. Sidoti upgraded shares of PetMed Express from a "neutral" rating to a "buy" rating and set a $47.00 price target on the stock in a research note on Thursday, August 24th. Finally, Zacks Investment Research lowered shares of PetMed Express from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 25th. The analyst recommendations from a month ago are 3 Buy, 0 Overweight, 0 Sell, 3 Hold and 0 Underweight. Current price level places the company's stock about -40.84% from the 52-week high and 35% away from the 52-week low.

Currently, Petmed Express Inc (PETS) has a 14-day ATR of 1.35. The Firm markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. The Business's product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.